Oxford Biomedica PLC
30 April 2007
Oxford BioMedica plc (the 'Company')
Director Shareholdings
The Company received notification on 27 April 2007 that, on that day, Dr. Susan
Kingsman, a director of the Company and wife of Professor Alan Kingsman, Chief
Executive Officer of the Company, sold 4,000,000 ordinary shares of 1p each in
the Company ('Ordinary Shares') at 48 pence per share. Following this
transaction, Dr. Kingsman is interested in 13,032,590 Ordinary Shares
representing 2.44 per cent. of the Company's issued share capital. This includes
8,293,451 Ordinary Shares held by Professor Alan Kingsman, 210,000 Ordinary
Shares held jointly by Alan and Susan Kingsman and 100,000 Ordinary Shares held
by the son of Alan and Susan Kingsman.
In addition, Andrew Wood and Peter Nolan, both Directors of the Company, have
today exercised options over 167,000 and 132,000 Ordinary Shares in the Company
respectively. Both directors have subsequently sold all of these Ordinary Shares
for 48 pence per share.
These shares were placed by Evolution Securities with institutional investors.
Following these transactions, the total interests of Andrew Wood and Peter Nolan
in the Company's Ordinary Shares and share options are as follows:
+-----------------------+----------------------+-----------------------------+
| |Ordinary Shares |Share Options |
+-----------------------+----------------------+-----------------------------+
|Andrew Wood |205,067 |1,428,923 |
+-----------------------+----------------------+-----------------------------+
|Peter Nolan |163,638 |906,162 |
+-----------------------+----------------------+-----------------------------+
The exercise price for the options exercised today was 19.25p per share. The
newly allotted shares are subject to a block listing, so are already listed.
Including these shares, the total number of the Ordinary Shares in issue is now
533,939,015.
30 April 2007
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.